Randomized withdrawal of long-term prednisolone treatment in rheumatoid arthritis: effects on inflammation and bone mineral density (Q46929682)

26 December 2017

title

Randomized withdrawal of long-term prednisolone treatment in rheumatoid arthritis: effects on inflammation and bone mineral density (English)

1 reference

26 December 2017

1 reference

1 reference

26 December 2017

author name string

Tengstrand B

series ordinal

1 reference

26 December 2017

Larsson E

series ordinal

1 reference

26 December 2017

Hafström I

series ordinal

1 reference

26 December 2017

publication date

1 September 2007

1 reference

26 December 2017

Scandinavian Journal of Rheumatology

published in

1 reference

26 December 2017

volume

1 reference

26 December 2017

issue

1 reference

26 December 2017

page(s)

351-358

1 reference

26 December 2017

Fifty years of experience with cortisone therapy in the study and treatment of rheumatoid arthritis

cites work

1 reference

https://api.crossref.org/works/10.1080%2F03009740701394021

Low-dose corticosteroids in rheumatoid arthritis. A meta-analysis of their moderate-term effectiveness

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03009740701394021

Meta-analysis of short-term low dose prednisolone versus placebo and non-steroidal anti-inflammatory drugs in rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03009740701394021

Low-dose prednisone therapy for patients with early active rheumatoid arthritis: clinical efficacy, disease-modifying properties, and side effects: a randomized, double-blind, placebo-controlled clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03009740701394021

The molecular basis for the effectiveness, toxicity, and resistance to glucocorticoids: focus on the treatment of rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03009740701394021

Can we use steroid hormones to immunomodulate rheumatic diseases? Rheumatoid arthritis as an example

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03009740701394021

Low dose long-term corticosteroid therapy in rheumatoid arthritis: an analysis of serious adverse events

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03009740701394021

Bone mass in patients with rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03009740701394021

Prednisone treatment of elderly-onset rheumatoid arthritis. Disease activity and bone mass in comparison with chloroquine treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03009740701394021

Rheumatoid arthritis, corticosteroid therapy and hip fracture

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03009740701394021

Bone mass measurement and bone metabolism in rheumatoid arthritis: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03009740701394021

Reduced bone formation in non-steroid treated patients with rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03009740701394021

Bone turnover in non-steroid treated rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03009740701394021

Excretion of pyridinium crosslinks correlates with disease activity and appendicular bone loss in early rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03009740701394021

Glucocorticoid therapy for immune-mediated diseases: basic and clinical correlates

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03009740701394021

Anti-inflammatory actions of steroids: molecular mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03009740701394021

The american rheumatism association 1987 revised criteria for the classification of rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03009740701394021

Minimization: A new method of assigning patients to treatment and control groups

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03009740701394021

Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03009740701394021

Self reported non-vertebral fractures in rheumatoid arthritis and population based controls: incidence and relationship with bone mineral density and clinical variables

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03009740701394021

The prevalence of vertebral deformity in european men and women: the European Vertebral Osteoporosis Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03009740701394021

Change in bone mineral density in patients with rheumatoid arthritis during the first decade of the disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03009740701394021

Calcium and vitamin D3 supplementation prevents bone loss in the spine secondary to low-dose corticosteroids in patients with rheumatoid arthritis. A randomized, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03009740701394021

Bone mineral density in patients with rheumatoid arthritis treated with infliximab

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03009740701394021

Measurement of patient outcome in arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03009740701394021

Oral corticosteroids and fracture risk: relationship to daily and cumulative doses

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03009740701394021

10.1080/03009740701394021

21 January 2018

Identifiers

DOI

1 reference

26 December 2017

1 reference

26 December 2017